I

Inovio Pharmaceuticals
D

INO

2.09000
USD
0.17
(8.85%)
مغلق
حجم التداول
21,173
الربح لكل سهم
-2
العائد الربحي
-
P/E
-0
حجم السوق
75,448,981
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AMRN
    -0.00210
    (-0.38%)
    0.55580 USD
    A
    APTX
    0
    (0%)
    0 USD
    A
    ARWR
    0.540
    (2.84%)
    19.560 USD
    A
    AXSM
    -1.870
    (-1.99%)
    91.870 USD
    C
    CRSP
    0.260
    (0.65%)
    40.520 USD
    E
    EDIT
    -0.03000
    (-2.40%)
    1.22000 USD
    I
    INO
    0.17000
    (8.85%)
    2.09000 USD
    S
    SRPT
    1.070
    (0.91%)
    118.040 USD
    V
    VCEL
    2.750
    (4.88%)
    59.070 USD
    V
    VKTX
    0.130
    (0.40%)
    32.640 USD
    المزيد
الأخبار
المقالات

العنوان: Inovio Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.